Urgent Palliative Care Medicines Cheshire West

The contracting process for urgent palliative care medicines was conducted by the NHS Cheshire and Merseyside Integrated Care Board. This award, a part of the Health Care Services under the Provider Selection Regime (PSR) Regulations 2023, focuses on supplying essential palliative care medications across Cheshire West. This contract was enabled through a limited procurement method without prior publication, recognising the urgent and unpredictable demand for specific palliative care drugs, mostly unavailable in community pharmacies.

The contract was approved on 12th March 2024, commenced on 1st April 2024, and will last until 31st March 2025. The procurement falls under the 'Health services' category, delivered throughout various pharmacy sites in Cheshire West (Region: UKD63). This tender presents a remarkable opportunity for local pharmacists and pharmacy chains to increase their involvement with public health services, particularly in specialised medicine distribution.

Businesses experienced in managing pharmaceutical stock efficiently, especially in a community setting, stand to benefit by being preferred providers within this health care scheme. Establishing reliable partnerships with NHS bodies can enhance business visibility and potentially lead to further contracts within the healthcare sector. The rewarded pharmacies, such as Rowlands Pharmacy, Wells Pharmacy, and Well Pharmacy, illustrate the potential for growth within large-scale health service companies committed to fostering strong regional networks.